Literature DB >> 16768686

Outcomes of a contemporary amputation series.

Tao S Lim1, Andrew Finlayson, James M Thorpe, Kishore Sieunarine, Bibombe P Mwipatayi, Anne Brady, Manzoor Abbas, Donna Angel.   

Abstract

BACKGROUND: The aim of this study was to determine the outcomes of a contemporary amputation series.
METHODS: A retrospective audit of 87 cases of major lower limb amputation from January 2000 to December 2002 from the Department of Vascular Surgery, Royal Perth Hospital, was conducted.
RESULTS: The mean age of the study population was 70.1 +/- 14.3 years; the male : female ratio was 3.35:1. Comorbid problems included diabetes (49.4%), smoking (81.6%), hypertension (77.0%), ischaemic heart disease (58.6%), stroke (25.3%), raised creatinine level (34.5%) and chronic airway limitation (25.3%). Preamputation vascular reconstructive procedures were common, 34.5% in a previous admission and 23.0% in the same admission. The main indication was critical limb ischaemia (75.9%) followed by diabetic infection (17.2%). There were 51 below-knee (58.6%), 5 through-knee (5.7%) and 31 above-knee (35.6%.) amputations. The below-knee amputation to above-knee amputation ratio was 1.65:1. The overall wound infection rate was 26.4%; the infection rates for below-knee (29.4%) and above-knee (22.6%) amputation did not differ significantly (P = 0.58). Revision rates were 17.6% for below-knee, 20% for through-knee and none for above-knee amputations. Twenty patients (23.0%) underwent subsequent contralateral amputation. Thirty-nine patients (44.8%) were selected as suitable for a prosthesis by a rehabilitation physician; 31 (79.5%) used the prosthesis both indoors and outdoors and 6 (15.4%) used it indoors only within 3 months. Cumulative mortality at 30 days, 6 months, 12 months and 24 months was 10.1, 28.7, 43.1 and 51.7%, respectively.
CONCLUSION: This series agrees with the current published work in finding that patients undergoing major lower limb amputation are older, with a high prevalence of comorbid conditions. Successful prosthesis rehabilitation depends on patient selection and a multidisciplinary approach. Despite a low immediate mortality, the overall long-term results of lower limb amputation remain dismal.

Entities:  

Mesh:

Year:  2006        PMID: 16768686     DOI: 10.1111/j.1445-2197.2006.03715.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  22 in total

1.  Chronic wounds in Australia: A systematic review of key epidemiological and clinical parameters.

Authors:  Laura McCosker; Ruth Tulleners; Qinglu Cheng; Stefan Rohmer; Tamzin Pacella; Nick Graves; Rosana Pacella
Journal:  Int Wound J       Date:  2018-09-26       Impact factor: 3.315

2.  Common mental disorders in patients undergoing lower limb amputation: a population-based sample.

Authors:  Marco Antonio Nunes; Newton de Barros; Fausto Miranda; José Carlos Baptista-Silva
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

3.  Amputations of limbs during the 2005 earthquake in Pakistan: a firsthand experience of the author.

Authors:  Syed Muhammad Awais; Usman Zafar Dar; Ayesha Saeed
Journal:  Int Orthop       Date:  2012-07-24       Impact factor: 3.075

4.  Predicting successful prosthetic rehabilitation in major lower-limb amputation patients: a 15-year retrospective cohort study.

Authors:  Inés Fajardo-Martos; Olga Roda; Ramón Zambudio-Periago; Aurora Bueno-Cavanillas; Fidel Hita-Contreras; Indalecio Sánchez-Montesinos
Journal:  Braz J Phys Ther       Date:  2017-11-07       Impact factor: 3.377

5.  Very low survival rates after non-traumatic lower limb amputation in a consecutive series: what to do?

Authors:  Morten Tange Kristensen; Gitte Holm; Klaus Kirketerp-Møller; Michael Krasheninnikoff; Peter Gebuhr
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-31

Review 6.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

7.  Rationale and design of the Clinical and Histologic Analysis of Mesenchymal Stromal Cells in AmPutations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia.

Authors:  S Keisin Wang; Linden A Green; Natalie A Drucker; Raghu L Motaganahalli; Andres Fajardo; Michael P Murphy
Journal:  J Vasc Surg       Date:  2018-02-01       Impact factor: 4.268

8.  Inflammatory "adiposopathy" in major amputation patients.

Authors:  Christine R Mauro; Binh T Nguyen; Peng Yu; Ming Tao; Ian Gao; Michael A Seidman; Louis L Nguyen; C Keith Ozaki
Journal:  Ann Vasc Surg       Date:  2013-04       Impact factor: 1.466

9.  Fate of the contralateral limb after lower extremity amputation.

Authors:  Julia D Glaser; Rodney P Bensley; Rob Hurks; Suzanne Dahlberg; Allen D Hamdan; Mark C Wyers; Elliot L Chaikof; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2013-08-03       Impact factor: 4.268

10.  Functional outcome after redo below-knee amputation.

Authors:  Chad N Stasik; Scott A Berceli; Peter R Nelson; W Anthony Lee; C Keith Ozaki
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.